Back to Rheumatology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Rheumatoid Arthritis

Overview

Spherix’s coverage of the rheumatoid arthritis segment focuses on tracking brand usage and changes in the treatment paradigm with increasing interest in alternate mechanisms of action in the US and the EU5. We also provide detailed insights in patient characteristics that influence treatment switching decisions.

Services Available

Trending market evolution

  • Rheumatoid Arthritis (US)

  • Rheumatoid Arthritis (EU)

Exploring the patient journey

  • Biologic/Small Molecule Switching in RA (US)

  • Biologic/Small Molecule Switching in RA (EU)

Benchmarking new brand performance

  • Artlegia (R-Pharm) in Rheumatoid Arthritis (US)*

*Pending approvals and launch

gauging impact of disruptive events

  • Multi Specialty Impact of COVID 19 Rheumatology (US)

  • PCP Treatment of Rheumatology (US)

  • Pediatric Rheumatology (US)

  • Rheumatology Biosimilars Today and Tomorrow (US)

  • The Impact of Biosimilar Usage in Rheumatology (US)

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Rheumatoid Arthritis Coverage